We are a portfolio biopharmaceutical company. We translate breakthroughs in biology and basic medical research into innovative new medicines.

Find the latest Apollo Global Management, Inc. (APO) stock quote, history, news and other vital information to help you with your stock trading and ...

Information on valuation, funding, cap tables, investors, and executives for Apollo Therapeutics. Use the PitchBook Platform to explore the full profile.

Key Data. Open $176.06; Day Range 171.90 - 176.11; 52 Week Range 88.59 - 176.75; Market Cap $99.03B; Shares Outstanding 565.82M; Public Float 397.7M ...

Find the latest Apollo Global Management, Inc. (APO-PA) stock quote, history, news and other vital information to help you with your stock trading and ...

Apollo Therapeutics Closes $226.5 Million Series C Financing Led by Patient Square Capital · $226.5m million raised. · Financing led by Patient Square Capital.

Key Stats · Market Cap99.035B · Shares Out565.82M · 10 Day Average Volume3.99M · Dividend1.85 · Dividend Yield1.06% · Beta1.62 · YTD % Change84.93.

Discover real-time Apollo Global Management, Inc. (New) Common Stock (APO) stock prices, quotes, historical data, news, and Insights for informed trading ... Pre-Market · After-Hours · Real-Time · Dividend History

Complete Apollo Global Management Inc. stock information by Barron's. View real-time APO stock price and news, along with industry-best analysis.

Information on valuation, funding, cap tables, investors, and executives for Apollo (Therapeutic Devices). Use the PitchBook Platform to explore the full ...